News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer AG (BAY.F)'s Xarelto Blood Thinner Matched Warfarin in Japanese Safety Study


7/25/2011 8:06:38 AM

Bayer AG (BAYN)’s Xarelto blood-thinner didn’t raise the risk of bleeding for irregular-heartbeat patients in a Japanese study comparing the medicine with warfarin, the former standard of care, the Leverkusen, Germany- based company said today. The results confirmed those of the global Rocket study, Bayer said. The German drug and chemicals maker said in April it requested Japanese approval for Xarelto for irregular-heartbeat patients.

Read at Bloomberg
Read at Expactica
Read at News Release


comments powered by Disqus
Bayer AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES